Belite Bio Inc - American Depositary Shares —— 资产负债表 (NASDAQ:BLTE) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 44.27 M94.64 M152.13 M780.56 M 负债总额 2.77 M4.21 M6.31 M10.07 M 权益总额 41.5 M90.43 M145.82 M770.49 M 负债及股东权益总额 44.27 M94.64 M152.13 M780.56 M 总债务 866 K——— 净债务 -41.22 M———

新闻

Belite Bio在Leerink会议上展示:Tinlarebant临床试验前景可期

Belite Bio at Leerink Conference: Tinlarebant’s Promising Trials

瑞穗重申Belite Bio股票评级,公司更新新药申请时间表

Mizuho reiterates Belite Bio stock rating on NDA timeline update

H.C. Wainwright上调Belite Bio目标价,基于新药申请时间表

H.C. Wainwright raises Belite Bio stock price target on NDA timeline

Belite Bio, Inc 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:BLTE) 2026-03-03

Benchmark基于试验数据将Belite Bio目标价上调至217美元

Belite Bio stock price target raised to $217 by Benchmark on trial data

Cantor Fitzgerald上调贝莱特生物股票目标价,看好定价前景

Cantor Fitzgerald raises Belite Bio stock price target on pricing outlook

Belite Bio, Inc (BLTE) Q4 2025 Earnings Call Transcript